Infinity Pharmaceuticals Inc expected to post a loss of 13 cents a share - Earnings Preview

Infinity Pharmaceuticals

30/10/2021 03:06

* Infinity Pharmaceuticals Inc  INFI.OQ   INFI.O  is expected
to show a rise in quarterly revenue when it reports results on
November 2. 
* The Cambridge, Massachusetts-based company is expected to
report  a 5.6% increase in revenue to $523.67 thousand from $496
thousand a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Infinity
Pharmaceuticals Inc is for a loss of 13 cents per share. For the
same quarter last year, the company reported a loss of 16 cents
per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $9​, about 71.8% above​ its last closing
price of $2.54. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.14       -0.14      -0.13     Beat    4.4
 Mar. 31 2021  -0.12       -0.12      -0.15     Missed  -20.2
 Dec. 31 2020  -0.16       -0.16      -0.16     Met     -2.1​
 Sep. 30 2020  -0.15       -0.16      -0.16     Met     -2.6
 Jun.          -0.20​      -0.19      -0.16     Beat    16.1​
 30​ 2020​                                              
 Mar. 31 2020  -0.12       -0.13      -0.19     Missed  -43.7​
 Dec. 31 2019  -0.19       -0.19      -0.20     Missed  -4.7
 Sep. 30 2019  -0.13       -0.10      -0.20     Missed  -109.4
 This summary was machine generated October 30 at 02:06 GMT.  All
figures in US dollars unless otherwise stated